translation agency

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update
CALIFORNIA: S.F. Mayor Lee Celebrates Opening of City's New Bridge HIV Research Facility
Valerie Gotten
October 1, 2012
California Newswire (09.28.12)

San Francisco Mayor Edwin M. Lee officially cut the ribbon to open the San Francisco Department of Public Health’s (DPH) new Bridge HIV research facility, which is part of San Francisco’s new $9.5 million HIV/AIDS Research Center. “The research that has come out of the San Francisco AIDS Office has changed the way we look at, treat, and prevent the spread of HIV/AIDS all over the world. The new state-of-the-art Bridge HIV facility reflects the commitment and integrity of the work that goes on here, and we have produced a new innovative world class center for world class researchers,” said Mayor Lee. Dignitaries such as Democratic Leader Nancy Pelosi, DPH Director Barbara Garcia, and Department of Public Works (DPW) Director Mohammed Nuru all spoke at the opening of the new facility. The Bridge HIV facility completion marks the end of phase one of the SOAR project (San Francisco Office of AIDS Renovation). The project is financed by a grant through the National Center for Research Resources at the National Institutes of Health (NIH) and is part of the American Recovery and Reinvestment Act (ARRA). The new 17,000 square feet HIV/AIDS research center will expand and improve the current research activities and accommodate future scientific needs. Thirty years after the discovery of the virus that causes AIDS, the San Francisco DPH’s AIDS Office has matured into three independent and collaborative grant-funded research units managing a $46 million research portfolio. The three units are (1) Bridge HIV (formerly HIV Research Section), a leading site in the NIH-funded HIV Vaccine Trials Network, the Prevention Trials Network, the clinical trial groups of HIV Pre-Exposure Prophylaxis (PreP), and other investigator-initiated research; (2) the HIV Epidemiology Section, which evaluates the incidence and prevalence of persons with HIV/AIDS; and (3) the HIV Prevention Section, the leading site for the National Institute of Drug Abuse AIDS-funded Clinical Trials Network.

www.aegis.org